XML 22 R4.htm IDEA: XBRL DOCUMENT v3.23.4
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Net revenue            
Total net revenue $ 4,481 $ 3,294 $ 11,916 $ 10,981 $ 14,868 $ 5,679
Cost of net revenue 2,445 2,000 7,346 6,747 8,915 3,270
Gross profit 2,036 1,294 4,570 4,234 5,953 2,409
Operating expenses            
Research and development 3,484 4,509 11,038 15,636 19,768 11,471
Selling, general and administrative 2,112 3,353 6,331 8,938 11,108 7,016
Gain on license and asset sale (2,557) (406) (2,557) (2,557)  
Total operating expenses 5,596 5,305 16,963 22,017 38,265 18,487
Impairment of goodwill         9,946
Loss from operations (3,560) (4,011) (12,393) (17,783) (32,312) (16,078)
Interest expense         (16) (2,979)
Change in fair value of warrant liabilities 2,615 4,239 1,595 8,102
Financing cost - warrant issuance         (1,576)  
Other income/(expense), net 322 3 297 (22) (89) 44
Net loss (623) (4,008) (7,857) (17,805) (32,398) (10,911)
Other comprehensive loss, net of tax:            
Net unrealized gain (loss) on available-for-sale securities 4 5 25 (36) (25)  
Comprehensive loss $ (619) $ (4,003) $ (7,832) $ (17,841) $ (32,423) $ (10,911)
Net loss per share            
Basic (in Dollars per share) $ (0.87) $ (8) $ (12.63) $ (35.68) $ (64.41) $ (74.22)
Shares used in computing net loss per share            
Shares used in computing net loss per share, basic (in Shares) 715 501 622 499 503 147
Product            
Net revenue            
Total net revenue $ 4,262 $ 3,060 $ 11,385 $ 10,384 $ 14,199 $ 4,906
Royalty and other            
Net revenue            
Total net revenue $ 219 $ 234 $ 531 $ 597 $ 669 $ 773